Healthy Extracts Inc. (OTCQB:HYEX) has revealed a remarkable increase in its net revenue, projecting over $3.6 million for the first half of 2026. This figure represents a 93% rise compared to the same period in 2025, further solidifying the company's trajectory toward double-digit revenue growth.
The notable revenue growth can be attributed to a series of strategic acquisitions and partnerships. In May, the company acquired Imaraïs Beauty, a brand recognized for its plant-based beauty and wellness products. The move is expected to enhance Healthy Extracts' product offerings and distribution channels significantly.
Healthy Extracts' subsidiary, Gummy USA, had already entered a manufacturing partnership with Imaraïs Beauty earlier in April, which saw an initial order of nearly 4 million gummies positioned for retail distribution across over 4,000 store locations in the United States. This collaboration has been a key factor in increasing Healthy Extracts' market presence.
For the second quarter of 2026, Healthy Extracts anticipates net revenues to surpass $2.0 million, marking an increase of over 112% sequentially and 129% year-over-year. This growth is part of the company’s ninth consecutive quarter of year-over-year revenue growth, aligning with its broader goal of expanding into high-growth sectors.
The company aims to achieve an annualized net revenue exceeding $20 million by the end of the year, contingent on the current sales pipeline and manufacturing capabilities. Management underscores the importance of their precision dosing technology and innovative delivery systems as essential components in differentiating their offerings in the nutraceutical and wellness markets.
CEO Don Swanson stated that the integration with Imaraïs Beauty and the merger with Gummy USA presents ample opportunities for expanding distribution and advancing product development. Healthy Extracts is positioned to leverage the growing demand in the health and beauty market, projected to exceed $730 billion this year.
Healthy Extracts reported an expected net revenue of over $3.6 million for the first half of 2026, marking an increase of more than 93% compared to the first half of 2025.
The acquisition of Imaraïs Beauty, which became a wholly owned subsidiary of Healthy Extracts, has reportedly expanded the company's product lines, distribution channels, and generated new B2B customers. However, actual operational performance will depend on the successful integration of the acquisition.
For the second quarter of 2026, Healthy Extracts anticipates net revenue to exceed $2.0 million, an increase of over 112% sequentially and 129% compared to the same quarter the previous year.
Gummy USA, which merged with Healthy Extracts, is noted for its precision-dose gummy manufacturing technology and has contributed to the company's growth by addressing unmet needs in the nutraceutical and pharmaceutical sectors.
Imaraïs Beauty products are distributed across various major U.S. retail channels, including Target, Ulta Beauty, and Sprouts, among others. This broad distribution reflects the brand's market reach, though performance may vary across these channels.
Healthy Extracts is projecting the potential to achieve annualised net revenue of more than $20 million by year-end 2026, though this is described as an aggressive goal contingent on current sales pipelines and existing manufacturing capabilities.
The forward-looking statements made by Healthy Extracts involve significant risks, uncertainties, and assumptions, with actual results potentially differing materially from projections. Investors are encouraged to review the risk factors provided in the company's filings with the SEC.
Healthy Extracts develops and markets science-based products including BergametNA™ and Ultimate Brain Nutrients™ (UBN™). The company focuses on beauty, wellness, and health through proprietary formulations and advanced delivery technologies.